Literature DB >> 23943818

Intermittent balloon occlusion to favor nidal penetration during embolization of arteriovenous malformations: a technique modification.

William O Bank1, Andrew B Stemer, Rocco A Armonda, Randy S Bell.   

Abstract

Endovascular embolization of brain arteriovenous malformations (AVMs) has improved with liquid occlusive agents, but flow-related and anatomic restrictions limit endovascular capabilities. AVM compartments supplied by leptomeningeal networks and feeding arteries too small and/or tortuous for safe catheterization are rarely penetrated by liquid occlusive agents. A case with both impediments prompted a novel solution. A balloon was inflated across the supply to a lenticulostriate feeder, thereby favoring penetration of the liquid occlusive agent, injected from a different feeding territory, back into the AVM compartment supplied by the temporarily occluded feeder. This technique may reduce the number of embolization stages in large high-flow AVMs and increase the likelihood of achieving complete occlusion. This technique is highly complex and requires meticulous monitoring of multiple events.

Entities:  

Keywords:  Arteriovenous Malformation; Balloon; Brain; Intervention; Liquid Embolic Material

Mesh:

Year:  2013        PMID: 23943818     DOI: 10.1136/neurintsurg-2012-010637.rep

Source DB:  PubMed          Journal:  J Neurointerv Surg        ISSN: 1759-8478            Impact factor:   5.836


  2 in total

1.  S-shaped distal access catheter supported microcatheter navigation into the lenticulostriate artery feeders of brain arteriovenous malformations.

Authors:  Satoshi Koizumi; Masaaki Shojima; Osamu Ishikawa; Hirotaka Hasegawa; Satoru Miyawaki; Hirofumi Nakatomi; Nobuhito Saito
Journal:  Interv Neuroradiol       Date:  2020-06-19       Impact factor: 1.610

2.  Embolization of brain arteriovenous malformations with the diluted Onyx technique: initial experience.

Authors:  Haowen Xu; Li Wang; Sheng Guan; Dongdong Li; Tao Quan
Journal:  Neuroradiology       Date:  2019-02-02       Impact factor: 2.804

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.